Calendrier des promotions National Research Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise National Research Corporation
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Paramètres de base
IPO date
1997-10-10
ISIN
US6373722023
Industry
Health Care Providers & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
2.99
Дивиденд ао
0.24
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 2.89 | 6 |
P/BV | 13.21 | 1 |
P/E | 16.68 | 7 |
Efficacité
Nom | Signification | Grade |
ROA | 19.44 | 6 |
ROE | 61.77 | 10 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 5.08 | 10 |
DSI | 0.8571 | 8.57 |
Croissance moyenne du dividende | -19.51 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 1.52 | 7 |
Debt/Ratio | 0.4729 | 10 |
Debt/Equity | 3.24 | 4 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 7.32 | 1 |
Rentabilité Ebitda, % | -17.88 | 0 |
Rentabilité EPS, % | -28.01 | 0 |
Dividendes
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 16.04 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 16.21 $ | 0 $ | 0 $ | -1.05 % | 0 % | 0 % |
common.calendar.number_days.30d | 13.59 $ | 15.02 $ | 16.21 $ | 18.03 % | 0 % | 0 % |
common.calendar.number_days.90d | 10.7 $ | 10.13 $ | 16.21 $ | 49.91 % | 0 % | 0 % |
common.calendar.number_days.180d | 16.82 $ | 10.13 $ | 18.73 $ | -4.64 % | 0 % | 0 % |
common.calendar.number_days.1y | 22.11 $ | 10.13 $ | 26.17 $ | -27.45 % | 0 % | 0 % |
common.calendar.number_days.3y | 34.22 $ | 10.13 $ | 47.17 $ | -53.13 % | 0 % | 0 % |
common.calendar.number_days.5y | 57.45 $ | 10.13 $ | 59.98 $ | -72.08 % | 0 % | 0 % |
common.calendar.number_days.10y | 10.13 $ | 10.13 $ | 70.35 $ | 158.34 % | 0 % | 0 % |
common.calendar.number_days.ytd | 16.67 $ | 10.13 $ | 18.73 $ | -3.78 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
iShares Morningstar Small-Cap Growth ETF | 0.01365 | 601.87 | 0.06 |
iShares Morningstar Small-Cap ETF | 0.00669 | 328.78 | 0.25 |
0,01 | 465,32 | 0,15 |
---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Michael D. Hays | Founder, CEO, President & Director | 131.11k | 1955 (70 années) |
Ms. Helen L. Hrdy | Chief Customer Officer | 291.51k | 1965 (60 années) |
Mr. Jon Boumstein | Chief Delivery Officer | N/A | |
Megan Charko | Senior Manager of Content Marketing | N/A | |
Mr. Christophe Louvion | Chief Product & Technology Officer | N/A | 1973 (52 année) |
Mr. Andy Monnich | Chief Corporate Development Officer | N/A | 1976 (49 années) |
Mr. Jason Hahn | Chief Revenue Officer | N/A | 1972 (53 année) |
Ms. Linda Stacy | Secretary | N/A | |
Ms. Vinitha Ramnathan | Chief Product Officer |
Informations sur l'entreprise
Adresse: United States, Lincoln. NE, 1245 Q Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.nrchealth.com
Site web: https://www.nrchealth.com